Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geny Piro

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Scientific Reports|August 24, 2019
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic diseaseDea Filippini, Sabrina D' Agosto, Pietro Delfino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer PatientsGeny Piro, Carmine Carbone, Ivana Cataldo, et al.
Nature Communications|March 30, 2024
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous NeoplasmsAntonio Agostini, Geny Piro, Frediano Inzani, et al.
British Journal of Cancer|November 17, 2022
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancerGeny Piro, Carmine Carbone, Antonio Agostini, et al.
Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.
Scientific Reports|June 25, 2021
Molecular alterations in basal cell carcinoma subtypesLucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani, et al.
Frontiers in Cell and Developmental Biology|May 16, 2020
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis <i>in vivo</i>Francesca Lupo, Geny Piro, Lorena Torroni, et al.
Cancer Communications (London, England)|May 18, 2026
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to <i>Kras</i> <sup>G12D</sup> Inhibition in Pancreatic CancerAlessia Caggiano, Antonio Agostini, Diego Iacuone, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinomaErika Testa, Clara Dezi, Francesca Lovat, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Scientific Reports|August 24, 2019
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic diseaseDea Filippini, Sabrina D' Agosto, Pietro Delfino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer PatientsGeny Piro, Carmine Carbone, Ivana Cataldo, et al.
Nature Communications|March 30, 2024
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous NeoplasmsAntonio Agostini, Geny Piro, Frediano Inzani, et al.
British Journal of Cancer|November 17, 2022
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancerGeny Piro, Carmine Carbone, Antonio Agostini, et al.
Clinical Lung Cancer|February 9, 2021
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase InhibitorsMiriam Grazia Ferrara, Maurizio Martini, Ettore D'Argento, et al.
Scientific Reports|June 25, 2021
Molecular alterations in basal cell carcinoma subtypesLucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani, et al.
Frontiers in Cell and Developmental Biology|May 16, 2020
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis <i>in vivo</i>Francesca Lupo, Geny Piro, Lorena Torroni, et al.
Cancer Communications (London, England)|May 18, 2026
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to <i>Kras</i> <sup>G12D</sup> Inhibition in Pancreatic CancerAlessia Caggiano, Antonio Agostini, Diego Iacuone, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinomaErika Testa, Clara Dezi, Francesca Lovat, et al.
Pageof 6